生物效应预测和纳米粒子重新设计的可解释因果系统优化框架
Xu Dong1, Xiangang Hu1, Fubo Yu1
1Key Laboratory of Pollution Processes and Environmental Criteria (Ministry of Education), Carbon Neutrality Interdisciplinary Science Centre, College of Environmental Science and Engineering, Nankai University, Tianjin 300350, China.
本研究引入了一个可解释的因果系统优化 (ICSO) 框架,以提高纳米材料的安全性和有效性. 在纳米医学应用中优化纳米粒子特性以减少炎症和增强器官输送.
科学领域:
- 纳米医学
- 生物材料科学
- 毒理学
背景情况:
- 纳米材料具有治疗潜力,但面临着纳米毒性和炎症等安全挑战.
- 了解生物-纳米粒子相互作用对于安全有效的纳米医学至关重要.
- 在纳米粒子 (NP) 生物应用中,平衡免疫反应和器官负担是关键.
研究的目的:
- 开发一个可解释的因果系统优化 (ICSO) 框架来预测和优化纳米粒子 (NP) 的行为.
- 确定影响免疫反应和器官负担的关键驱动因素.
- 为设计生物相容和有针对性的器官输送纳米材料提供定量见解.
主要方法:
- 开发了一个可解释的因果系统优化 (ICSO) 框架.
- 为NP设计构建上游 (预测) 和下游 (优化) 任务.
- 对生物反应进行查的关键驱动因素 (例如,特定表面积,大小) 和因果信息.
- 对NP属性的量化生物响应值 (例如zeta潜力).
主要成果:
- 确定了生物纳米相互作用的关键驱动因素和因果因素,揭示了原始化/约束效应.
- 对各种NP属性的量化生物响应值.
- 通过ICSO驱动优化显著减少炎症 (36. 19%) 和增加肺积累 (40. 14%).
- 优化的参数包括特定的表面积,形状和直径与长度的比率.
结论:
- ICSO框架为纳米材料设计提供了一种强大的,自动化的替代方法.
- ICSO为开发更安全,更有效的纳米药物提供了关键的定量数据和限制.
- 这种方法有助于设计高生物相容性和有针对性的器官输送纳米材料.
更多相关视频
11:53Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Drug Discovery: Overview
